Outset Medical
93 hedge funds and large institutions have $59.8M invested in Outset Medical in 2026 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 27 reducing their positions, and 24 closing their positions.
1,035% more call options, than puts
Call options by funds: $556K | Put options by funds: $49K
19% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 27
4% more capital invested
Capital invested by funds: $57.3M → $59.8M (+$2.5M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less funds holding
Funds holding: 99 → 93 (-6)
6.57% less ownership
Funds ownership: 81.27% → 74.7% (-6.6%)
17% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$2.7M |
| 2 |
PLC
Peapod Lane Capital
Bedford Hills,
New York
|
+$1.45M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$927K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$834K |
| 5 |
Millennium Management
New York
|
+$795K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.7M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$1.24M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$1.12M |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.11M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$948K |
OM Hedge Fund Activity: Q2 2026 in Review
93 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q2 2026, worth a combined $59.8M — up 4.4% from $57.3M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of OM and 20 opened new positions — a net loss of 4 holders — while 27 trimmed existing stakes and 32 added.
The largest buyer was BML Capital Management, adding an estimated $2.7M. The largest seller was BlackRock, cutting an estimated $3.7M.
- 93 institutional investors held Outset Medical (OM) as of Q2 2026, down from 99 in Q1 2026.
- Funds reported $59.8M of Outset Medical stock for Q2 2026, up 4.4% quarter-over-quarter.
- 20 funds opened new Outset Medical positions in Q2 2026 and 24 closed out, a net change of -4 holders.
- The largest Outset Medical buyer in Q2 2026 was BML Capital Management, an estimated $2.7M added.
- The largest Outset Medical seller in Q2 2026 was BlackRock, an estimated $3.7M sold.
Based on aggregated 13F filings for Q2 2026.